WHO’s PQP: How affordable antiretroviral and other treatments owe much to “little known part of WHO” reliant on two funders
In 1999, a small South Africa study revealed disturbing news about a medicine used in first line directly observed therapy for tuberculosis: it contained the right amount of the most essential ingredient but testing showed it was not being absorbed into patients’ systems. If the small study was representative of what was happening on a […]